These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11682907)

  • 1. What can I do to continue walking despite intermittent claudication?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):8. PubMed ID: 11682907
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of patients with intermittent claudication.
    Olin JW
    Int J Clin Pract; 2002 Nov; 56(9):687-93. PubMed ID: 12469984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can claudication be improved with medication?
    Conners MS; Money SR
    Semin Vasc Surg; 2002 Dec; 15(4):237-44. PubMed ID: 12478498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication?
    Weismantel D
    J Fam Pract; 2001 Feb; 50(2):181. PubMed ID: 11219570
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of intermittent claudication: cilostazol.
    Collins P; Brittenden J
    Hosp Med; 2004 Aug; 65(8):466-70. PubMed ID: 15330347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol for intermittent claudication.
    Med Lett Drugs Ther; 1999 May; 41(1052):44-6. PubMed ID: 10368703
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of cilostazol (Pletal) in the management of intermittent claudication.
    Bradbury AW
    Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol: improving walking distance in patients with intermittent claudication.
    Collinson DJ; Donnelly R
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):503-9. PubMed ID: 15225110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM; Virgini-Magalhães CE; Lencastre Sicuro F; Bottino DA; Bouskela E
    Angiology; 2008; 59(5):549-58. PubMed ID: 18388031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol.
    Cheng JW
    Heart Dis; 1999; 1(3):182-6. PubMed ID: 11720622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol approved for use in intermittent claudication.
    Miller JL
    Am J Health Syst Pharm; 1999 Mar; 56(5):404. PubMed ID: 10096695
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incomplete description of effect data in intermittent claudication].
    Nilsson KA; Cline C
    Lakartidningen; 2010 Sep 1-7; 107(35):2021. PubMed ID: 21043188
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipine, ticlopidine and cilostazol.
    Nakai K; Takenobu Y; Takimizu H; Akimaru S; Maegawa H; Ito H; Marsala M; Katsube N
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):253-63. PubMed ID: 14518565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in responsiveness to clopidogrel in patients with intermittent claudication.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):71-5. PubMed ID: 16549375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of verapamil in intermittent claudication.
    Switzer DS
    J Fam Pract; 1997 Apr; 44(4):337. PubMed ID: 9108822
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of cilostazol in the treatment of intermittent claudication.
    Barnett AH; Bradbury AW; Brittenden J; Crichton B; Donnelly R; Homer-Vanniasinkam S; Mikhailidis DP; Stansby G
    Curr Med Res Opin; 2004 Oct; 20(10):1661-70. PubMed ID: 15462700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of peripheral arterial disease.
    Finucane TE
    JAMA; 2006 Jul; 296(1):41; author reply 41-2. PubMed ID: 16820540
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent claudication revisited: the value of medical therapy.
    Hiatt WR
    Arch Intern Med; 1999 Sep; 159(16):1955-6. PubMed ID: 10493329
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical treatment in intermittent claudication.
    Verhaeghe R; Verstraete M
    Acta Cardiol; 1979; 34(3):153-61. PubMed ID: 315684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SBU meets criticism: "Read the entire Alert report on intermittent claudication"].
    Bergqvist D; Rolandsson O; Säwe J
    Lakartidningen; 2010 Sep 22-28; 107(38):2257. PubMed ID: 21043173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.